SUTENT

Capsule, hard, 25mg
RxActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength25mg
PackagingUkupno 28 kapsula tvrdih u blisteru (4x7) u kartonskoj kutiji
ManufacturerPfizer Italia S.r.l., Italy
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateNovember 8, 2022

Analogs in Montenegro

20

Other medicines with the same active substance

Data obtained from the official medicines registry of the CInMED Agency of Montenegro — cinmed.me ↗
Data updated: April 2026